Bacterial Vaginosis: What Do We Currently Know?
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The vaginal microbiome is a well-defined compartment of the human microbiome. It has unique conditions, characterized by the dominance of one bacterial species, the Lactobacilli. This microbiota manifests itself by a low degree of diversity and by a strong dynamic of change in its composition under the influence of various exogenous and endogenous factors. The increase in diversity may paradoxically be associated with dysbiosis, such as bacterial vaginosis (BV). BV is the result of a disturbance in the vaginal ecosystem; i.e., a sudden replacement of Lactobacilli by anaerobic bacteria such as Gardnerella vaginalis, Atopobium vaginae, Ureaplasma urealyticum, Mycoplasma hominis, and others. It is the most common cause of vaginal discharge in women of childbearing age, approximately 30% of all causes. The etiology of this dysbiosis remains unknown, but its health consequences are significant, including obstetrical complications, increased risk of sexually transmitted infections and urogenital infections. Its diagnosis is based on Amsel’s clinical criteria and/or a gram stain based on the Nugent score. While both of these methods have been widely applied worldwide for approximately three decades, Nugent score are still considered the “gold standard” of BV diagnostic tools. Given the limitations of these tools, methods based on molecular biology have been developed as alternative rational strategies for the diagnosis of BV. The treatment of BV aims at restoring the balance of the vaginal flora to stop the proliferation of harmful microorganisms. Prescription of antibiotics such as metronidazole, clindamycin, etc. is recommended. Faced with the considerable uncertainty about the cause of BV, the high rate of recurrence, the unacceptable treatment options, and clinical management which is often insensitive and inconsistent, research on this topic is intensifying. Knowledge of its composition and its associated variations represents the key element in improving the therapeutic management of patients with the most suitable treatments possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparative genomics of the lactic acid bacteria.
Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., Pavlov, A., Pavlova, N., Karamychev, V., Polouchine, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607117103 · Cited by 1,391
Molecular Identification of Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., & Marrazzo, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043802 · Cited by 1,303 · cited 1×
“As molecular techniques have advanced, our understanding of the diversity and complexity of the vaginal bacterial community has broadened (Fredricks et al., 2005).”
BackgroundRomero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection
Brotman, R. M., Shardell, M. D., Gajer, P., Tracy, J. K., Zenilman, J. M., Ravel, J., & Gravitt, P. E. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu330 · Cited by 411
The role of lactobacilli and probiotics in maintaining vaginal health
Borges, S., Silva, J., & Teixeira, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3064-9 · Cited by 397
Sherrard, J., Wilson, J., Donders, G., Mendling, W., & Jensen, J. S. (2018) · International Journal of STD & AIDS · doi:10.1177/0956462418785451 · Cited by 297
Brown, R. G., Marchesi, J. R., Lee, Y. S., Smith, A., Lehne, B., Kindinger, L. M., Terzidou, V., Holmes, E., Nicholson, J. K., Bennett, P. R., et al. (2018) · BMC Medicine · doi:10.1186/s12916-017-0999-x · Cited by 295
Anukam, K. C., Osazuwa, E., Osemene, G. I., Ehigiagbe, F., Bruce, A. W., & Reid, G. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.08.008 · Cited by 276
van Oostrum, N., De Sutter, P., Meys, J., & Verstraelen, H. (2013) · Human Reproduction · doi:10.1093/humrep/det096 · Cited by 255
Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation
Bradshaw, C. S., & Sobel, J. D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw159 · Cited by 245
Mastromarino, P., Macchia, S., Meggiorini, L., Trinchieri, V., Mosca, L., Perluigi, M., & Midulla, C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02112.x · Cited by 194 · cited 1×
“Nine studies from 1989 to 2014 tested the effectiveness of vaginal or oral Lactobacillus probiotics (Fredricsson et al., 1989; Hallén et al., 1992; Wewalka et al., 2002; Mastromarino et al., 2009; Hummelen et al., 2010; Hemalatha et al., 2012; Ling et al., 2013; Vujic et al., 2013; Vicariotto et al., 2014).”
BackgroundVujic, G., Jajac Knez, A., Despot Stefanovic, V., & Kuzmic Vrbanovic, V. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.12.031 · Cited by 159 · cited 1×
“Nine studies from 1989 to 2014 tested the effectiveness of vaginal or oral Lactobacillus probiotics (Fredricsson et al., 1989; Hallén et al., 1992; Wewalka et al., 2002; Mastromarino et al., 2009; Hummelen et al., 2010; Hemalatha et al., 2012; Ling et al., 2013; Vujic et al., 2013; Vicariotto et al., 2014).”
BackgroundMuzny, C. A., Blanchard, E., Taylor, C. M., Aaron, K. J., Talluri, R., Griswold, M. E., Redden, D. T., Luo, M., Welsh, D. A., Van Der Pol, W. J., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy243 · Cited by 145
Clinical Validation of a Test for the Diagnosis of Vaginitis
Gaydos, C. A., Beqaj, S., Schwebke, J. R., Lebed, J., Smith, B., Davis, T. E., Fife, K. H., Nyirjesy, P., Spurrell, T., Furgerson, D., et al. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002090 · Cited by 144
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.
Marrazzo, J. M., Fiedler, T. L., Srinivasan, S., Thomas, K. K., Liu, C., Ko, D., Xie, H., Saracino, M., & Fredricks, D. N. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis242 · Cited by 123 · cited 2×
“However, it appears that, with the formation of bacterial biofilms, these recommended therapies only temporarily eradicated BV-associated microorganisms, or these bacteria are reintroduced in the vagina by their sex partners (Marrazzo et al., 2012; Bradshaw and Brotman, 2015; Margolis and Fredricks, 2015).”
BackgroundDNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo
Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit047 · Cited by 96 · cited 1×
“Including DNase agents that can disrupt vaginal biofilms by targeting extracellular DNA essential for their structural integrity (Hymes et al., 2013), retrocyclin 101, a synthetic cyclic antimicrobial peptide that inhibits the growth and development of G.”
BackgroundWessels, J. M., Lajoie, J., Vitali, D., Omollo, K., Kimani, J., Oyugi, J., Cheruiyot, J., Kimani, M., Mungai, J. N., Akolo, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187612 · Cited by 64
Cited by
Chien, M.-C., Huang, C.-Y., Wang, J.-H., Shih, C.-L., & Wu, P. (2024) · Nutrition & Diabetes · doi:10.1038/s41387-024-00296-0 · Cited by 87
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Metadata
- Authors
- Abou Chacra, L., Fenollar, F., & Diop, K.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-18
- Volume
- 11
- Pages
- 672429-672429
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W4205136760
- Cited by
- 223
- References
- 18
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.